2020
DOI: 10.1002/biot.201900274
|View full text |Cite
|
Sign up to set email alerts
|

Anything but Conventional Chromatography Approaches in Bioseparation

Abstract: While packed bed chromatography, known as conventional chromatography, has been serving the biopharmaceutical industry for decades as the bioseparation method of choice, alternative approaches are likely to take an increasing leading role in the next few years. The high number of new biological drugs under development, and the need to make biopharmaceuticals widely accessible, has been driving the academia and industry in the quest of anything but conventional chromatography approaches. In this perspective pap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
56
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 58 publications
(56 citation statements)
references
References 95 publications
0
56
0
Order By: Relevance
“…Technology Readiness Level (TRL) Index, introduced by NASA (Héder, 2017), can be used to assess the stage toward large-scale implementation where certain technology is located. The TRL index scale goes from 1 to 9, where TRL 1 concerns to fundamental concept/research, TRL 2-4 to technological research, TRL 5-8 to product demonstration, and TRL 9 to implementation (Roque et al, 2020).…”
Section: Future Prospectsmentioning
confidence: 99%
“…Technology Readiness Level (TRL) Index, introduced by NASA (Héder, 2017), can be used to assess the stage toward large-scale implementation where certain technology is located. The TRL index scale goes from 1 to 9, where TRL 1 concerns to fundamental concept/research, TRL 2-4 to technological research, TRL 5-8 to product demonstration, and TRL 9 to implementation (Roque et al, 2020).…”
Section: Future Prospectsmentioning
confidence: 99%
“…In this way, comparing a precipitation assay with the current protein A chromatography capture step, the lower costs associated (15–140 € per liter precipitant vs 5 000–14 000 € per liter protein A resin), [ 5 ] the scalability of the precipitation process already implemented in the downstream pipeline of biopharmaceuticals, [ 43,44 ] and the potential scale and implementation of magnetic fishing processes under cGMP equipment, [ 45 ] makes affinity magnetic precipitation a potential new platform for the capture of high added value proteins directly from the complex cell supernatant.…”
Section: Discussionmentioning
confidence: 99%
“…Stemming from the rapid growth in demand, significant improvements in upstream processing, such as more efficient fermentation and cell culture technologies, lead to an increase in titre production from an average 0.2 g/L in 1985 to 2.56 g/L in 2014. This shifted the bottleneck in manufacturing towards the downstream processing which heavily relies on costly multi-step packed-bed chromatography (2) and accounts for a total of up to 70% of the total production costs (3). Crystallisation as a purification technique is already widely adapted in the manufacturing of small molecules.…”
Section: Introductionmentioning
confidence: 99%